Key facts
- This page summarizes Timothy E. Baxter's Form 4 filing for PAVmed Inc. (PAVM).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 02 Oct 2025, 16:20.
Timothy E. Baxter - 30 Sep 2025 Form 4 Insider Report for PAVmed Inc. (PAVM)
- Role
- Director
- Signature
- /s/ Michael A. Gordon, by power of attorney
- Issuer symbol
- PAVM
- Transactions as of
- 30 Sep 2025
- Net transaction value
- $0
- Form type
- 4
- Filing time
- 02 Oct 2025, 16:20:04 UTC
- Previous filing
- 23 May 2025
- Next filing
- 03 Apr 2026
- SEC filing
- View on sec.gov
Reporting owner
Issuer context
Transaction snapshot
SEC evidence
Key filing fact
Timothy E. Baxter filed Form 4 for PAVmed Inc. (PAVM) on 02 Oct 2025.
Change
- Previous filing in this sequence was filed on 23 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001914275
Primary reporting owner
Baxter Timothy E
- Relationship
- Director
- Address
- 360 MADISON AVENUE, 25TH FLOOR, NEW YORK
- Signature
- /s/ Michael A. Gordon, by power of attorney
- Signature date
- 02 Oct 2025
Reported transactions
PAVM
transaction
Common stock
Award
- Transaction value
- $0
- Shares
- +150,000
- Change %
- +231%
- Price
- $0.000000
- Shares after
- 215,000
- Date
- 30 Sep 2025
- Ownership
- Direct
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents restricted stock granted to the reporting person under the issuer's Sixth Amended and Restated 2014 Long-Term Incentive Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed. |